US FDA to study quantitative effectiveness information in DTC ads
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is seeking comments on a study it intends to carry out on the presentation of quantitative effectiveness information to consumers in direct-to-consumer television and print advertisements for prescription drugs1. Comments must be submitted by 21 August.